[ET Net News Agency, 29 May 2023] KEYMED BIO-B (02162) fell 19.28% to HK$41.25, dipping
below the 250-D SMA of HK$47.893.
It hits an intra-day low of HK$40.8, hitting an 1-month low, and an intra-day high of
HK$48.6. The total shares traded was 522,000, with a value of HK$22.46m. The active
buy/sell ratio is 45:55, with net selling turnover of HK$1.85m. BARCLAYS CAPITAL ASIA
accounts for greatest net responsive buying turnover of HK$1.58m, with volume weighted
average price of HK$45.659. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive
selling turnover of HK$1.53m, with volume weighted average price of HK$42.422. The stock
has fallen a combined 27.7% over the past 3 consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 41.250 % Chg -19.28%
High 48.600 Low 40.800
Shares Tr 522,000 Turnover 22.46m
10-D SMA 55.445 %H.V 48.083
20-D SMA 58.525 VWAP 43.020
50-D SMA 60.900 RSI14 20.298
-----------------------------------
Status: Dipping below the 250-D SMA, hitting an 1-month low, active buy/sell ratio is
45:55, with net selling turnover of HK$1.85m, falling a combined 27.7% over the past 3
consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 41.25 -19.28
HUTCHMED (00013) 20.80 +3.23
GENSCRIPT BIO (01548) 18.40 -0.22
INNOVENT BIO (01801) 37.45 -0.79
JXR (01951) 4.12 -1.44
WUXI BIO (02269) 42.95 Unchanged
BEIGENE (06160) 143.90 +2.93
CANSINOBIO (06185) 30.45 -0.16
AKESO (09926) 36.80 -0.81
ALPHAMAB-B (09966) 8.47 -2.76
---------------------------------------------
(ed)